dante.llorenzodante.llorenzo Facebook ad: “Low dose Doxepin gets talked about a lot…”
Ran for 143 days, from May 28 to October 18, 2026, the last day Crush saw it.
Run by dante.llorenzo on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Make your own version of this ad
Crush makes it, launches it in your own Meta ad account, scales the winners and pauses the losers.
About this ad
- Meta Ad Library ID
- 962460416419663
- Platforms
- Facebook, Instagram, Audience Network, Messenger and Threads
- Relaunches
- 1
Ad text
Low dose Doxepin gets talked about a lot in optimization because of the histamine/wakefulness side of things. Which is interesting because most people only associate histamine with allergies… not with keeping the brain alert and active. That’s also why basic sleep supplements sometimes stop being enough for certain people. The issue isn’t always “not tired enough.” Sometimes the issue is that the nervous system never actually powers down. Real recovery starts there ⚙️ @algorx Code: KZN ⚡ #sleep #recovery #performance #optimization #doxepin
